Skip to main content

Table 3 Clinical features of the vertebral osteomyelitis patients, as determined by microbiological analysis of blood cultures or biopsies

From: The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine

Patient

Infectious agent

Microbiological method

Imaging method

1

S. epidermidis

5× biopsy

MRI

2

S. epidermidis

2× biopsy

CT

3

S. aureus (MRSA)

3× biopsy

MRI

4

Streptococcus dysgalactiae

1× blood culture

MRI

5

E. coli

4× blood culture

MRI

6

S. epidermidis

3× biopsy, 1× blood culture

MRI

7

E. coli

2× biopsy

MRI

8

S. aureus (MSSA)

2× biopsy

MRI

9

S. epidermidis

2× biopsy

MRI

10

Parvimonas micra

3× biopsy

MRI

11

Proprionibacterium acnes

3× biopsy

MRI

12

Streptococcus dysgalactiae

5× biopsy, 1× blood culture

MRI

13

S. aureus (MSSA)

3× biopsy, 1× blood culture

MRI

14

S. aureus (MSSA), E. coli

S. aureus (MSSA): 2× biopsy, 2× blood culture; E. coli: 4× biopsy, 4× blood culture

MRI

15

E. coli

3× biopsy

MRI

16

S. lugdunensis

2× biopsy

MRI

  1. S. Staphylococcus, MRSA methicillin-resistant S. aureus, MSSA methicillin-sensitive S. aureus, E. coli Escherichia coli. MRI magnetic resonance imaging, CT computed tomography